Loading...
In many parts of sub-Saharan Africa, cryptococcal meningitis (CM) is a common opportunistic infection among HIV-infected individuals. Facilities and resources to provide intravenous amphotericin B are often lacking in these areas, and oral fluconazole has been prescribed instead. Fluconazole doses of 200 to 400 mg daily are only fungistatic during the first 2 weeks of treatment and may predispose patients to the development of resistance. Might higher doses be more effective?
To find out, researchers performed a cohort study in southwestern Uganda among HIV-infected, antiretroviral therapy–naive adults with first-episode CM. The first 30 patients received 800 mg of fluconazole daily, and the next 30 received 1200 mg daily. Quantitative funga…